NewsPeople

Ravish Mittal is the new Group Chief Financial Officer Trivitron Healthcare

Bangalore: Trivitron Healthcare Private Limited, a leading medical device company providing affordable healthcare solutions to the healthcare industry, has announced the appointment of Ravish Mittal as Group Chief Financial Officer effective 9th December 2019.

Mr. Mittal, a qualified CA and Fellow member of the Institute of Directors (India & London) brings with him more than 25 years of varied experience across Strategic Direction, Business Partnering & Controlling, Mergers & Acquisitions, Joint Ventures, Treasury & Forex Management, Fund Raising, Project & Compliance Management in Multinational Corporations and promoter driven companies in India.

“We are delighted to have Ravish on-board Trivitron Group. In his new role, Mr. Mittal will be at the helm of the company’s finances, organisational growth and expansion plans. He will be a tremendous asset to Trivitron and our leadership team. We look forward to an exciting journey along with him and wish him all the success.’’ said, Dr GSK Velu, Chairman and MD, Trivitron Healthcare.

Commenting on his appointment, Mr. Ravish Mittal, Group CFO said, “It’s truly an exciting opportunity to join a market-leader like Trivitron Healthcare, especially in the current scenario wherein sizeable investment is expected in Healthcare space. Trivitron Healthcare is recognized as one of the country’s leading medical technology company. I am looking forward to working with this fantastic company as we continue to set the pace for our industry.”

Expressing her delight on the appointment Ms. Chandra Ganjoo, Executive Director, Group CPO & Head Corporate Communications, added, “We are very optimistic about this appointment. With his enthusiastic approach and a strong performance track record, Mr. Mittal will continue to drive the growth of Trivitron Group.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.
Tags

Related Articles

Leave a Reply

Back to top button
Close
Close